The Freya Newsroom

Find out the latest about Freya. Announcements, press coverage, and company info—it’s all here. 

Press releases

12th December, 2023

Freya Biosciences, a trans-Atlantic biotech company specializing in women’s health, announced today a $38 million Series A financing – one of the largest raises to advance women’s reproductive immunotherapies. 

27th June, 2023

Freya Biosciences Announces Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis

Freya Biosciences, a trans-Atlantic biotech company specializing in women’s health, announces positive topline results from its first Phase 1 clinical study of its lead asset FB101, an investigational vaginal microbial immunotherapeutic.